Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression - Preliminary open-label trial

Harefuah

Volumn 140, Issue 5, 2001, Pages 369-373+456

  Shiloh, R ^a   Weizman, A ^a   Weizer, N ^a   Dorfman Etrog, P ^a   Munitz, H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PYRIDOXINE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG EFFICACY; HUMAN; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIDOXINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0034924479     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. An investigation of post-psychotic depressive syndrome
2. Depression during the longitudinal course of schizophrenia
3. Depression in first episode schizophrenia
4. 'Akinetic depression' in schizophrneia
5. Depressive symptoms in acute schizophrenic hospitalized patient
6. The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia
7. Depression, demoralization, and control over psychotic illness: A comparison of depressed and non-depressed patients with chronic psychosis
8. The nature and prevalence of depression in chronic schizophrenic in-patients
9. Maintenance imipramine therapy for secondary depression in schizophrenia: A controlled trial
10. Negative and positive symptoms in schizophrneia and depression: A follow-up
11. Negative symptoms in schizophrneia and depression: Their longitudinal course and prognostic significance
12. Depression 'revealed' in schizophrenia
13. Depressive symptoms in schizophrenia: Comprehensive differential diagnosis
14. Dose of fluphenazine, familial expressed emotion and outcome in schizophrenia: Results of a two-year controlled study
15. Prospective prediction of schizophrenic remission
16. Prognostic factors in recovered and deteriorated schizophrenics
17. Treatment of schizoaffective disorder and schizohrenia with mood symptoms
18. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse
19. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial
20. Use of antidepressant drugs in schizophrenia
21. Response of postpsychotic depression to adjunctive imipramine or amitriptyline
22. Long-term treatment of mood disorders in schizophrenia
23. 6)
24. Pyridoxine in the treatment of premenstrual syndrome: A retrospective survey in 630 patients
25. 6
26. Characteristics of pyridoxine overdose neuropathy syndrome
27. 6 supplementation on premenstrual symptoms
28. 6) and the premenstrual syndrome: A randomized crossover trial
29. 6 in the treatment of premenstrual syndrome: Systematic review
30. 6 against premenstrual tension. A controlled clinical trial
31. A double-blind trial of four medications to treat severe premenstrual syndrome
32. 6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction
33. 6 treatment in women with major depression
34. 6 in subjects reacting to monosodium glutamate by the Chinese restaurant syndrome
35. The relationship between ECT nonresponsiveness and calcification of the pineal gland in bipolar patients
36. Pyridoxine and socialization
37. The brief psychiatric rating scale
38. A rating scale for depression
39. Molecular pathology of schizophrenia: More than one disease process?
40. Negative symptoms in schizophrenia and depression